Transdermal drug delivery provides a multi-billion dollar market for close to 20 drugs or drug combinations, but has yet to make impact on delivery of biopharmaceuticals. Recent advances are about to change that. Novel physical approaches to increase skin permeability have enabled delivery of proteins, vaccines and DNA and are poised to become products. This session will address topics to include microneedles, thermal poration, and micro-jet injectors.

• Educate attendees about recent advances in technology that enable transdermal delivery of drugs that previously could be administered only by hypodermic injection
• Compare novel transdermal delivery methods to elucidate their relative strengths and weaknesses
• Provide a forum for discussion about which biopharmaceuticals and vaccines are most suitable for transdermal delivery